Abstract:Background: Therapeutic cloning is the combination of somatic cell nuclear transfer (SCNT) and embryonic stem cell (ES) techniques to create specific ES cells that match those of a patient. Because ES cells derived by nuclear transfer (SCNT ES cells) are genetically identical to the donor, it will not generate rejection by the host's immune system and thus therapeutically may be more acceptable. Induced pluripotent stem cells (iPS) are a type of pluripotent stem cell artificially derived from an adult somatic cell by inducing a forced expression of a set of specific pluripotent genes. In the past few years, rapid progress in reprogramming and iPS technology has been made, and it seems to shadow any progress made in SCNT programs.Objective: This review compares the application perspective of SCNT with that of iPS in regenerative medicine.Methods: We conducted a literature search using the MEDLINE (PubMed), Wiley InterScience, Springer, EBSCO, and Annual Reviews databases using the keywords "iPS", "ES", "SCNT" "induced pluripotent stem cells", "embryonic stem cells", "therapeutic cloning", "regenerative medicine", and "somatic cell nuclear transfer". Only articles published in English were included in this review.Results: These two methods both have advantages' and disadvantages. Nevertheless, by using SCNT to generate patient-specific cell lines, it eliminates complications by avoiding the use of viral vectors during iPS generation. Success in in vitro matured eggs from aged women and even differentiation of oocytes from germ stem cells will further enhance the application of SCNT in regenerative medicine.Conclusion: Human SCNT may be an appropriate mean of generating patient stem cell lines for clinical therapy in the near future.

Therapeutic Cloning: the Progresses, Opportunities and Challenges

[Nuclear Transfer and Therapeutic Cloning].

[Therapeutic Cloning and Somatic Cell Reprogramming: Every Road Leads to Rome].

Human Therapeutic Cloning, Pitfalls And Lack Luster Because Of Rapid Developments In Induced Pluripotent Stem Cell Technology

Advance in the Role of Epigenetic Reprogramming in Somatic Cell Nuclear Transfer-Mediated Embryonic Development

Reproductive cloning in humans and therapeutic cloning in primates: is the ethical debate catching up with the recent scientific advances?

Progress and Challenges of Cell Replacement Therapy for Neurodegenerative Diseases Based on Direct Neural Reprogramming

Progress in embryonic stem cell-based organ cloning

Current Progress and Prospects in Rabbit Cloning

Progress on Somatic Cell Nuclear Transfer

Therapeutic and reproductive cloning: a critique

Chemical strategies for stem cell biology and regenerative medicine.

Nuclear transfer: Progress and quandaries

The Progress of Induced Pluripotent Stem Cells Research in China

Advancements and challenges in stem cell transplantation for regenerative medicine

Stem Cell Therapy: Challenges Ahead

Germline Stem Cells: A Useful Tool for Therapeutic Cloning

Successful Reprogramming of Differentiated Cells by Somatic Cell Nuclear Transfer, Using in Vitro-Matured Oocytes with a Modified Activation Method.

A brief review of recent advances in stem cell biology.

Lessons Learned from Somatic Cell Nuclear Transfer

A Brief Review of Recent Advances in Stem Cell Biology